Bristol-Myers exec appointments
Executive Summary
Charles Heimbold, Jr., former senior vice-president, promoted to exec VP with continued responsibility for company's Consumer Products Group, Health Care Group and its Planning and Development divisions; Michael Autera, former senior VP, to exec-VP, retaining present administrative responsibilities including duties as chief financial officer; Stephen Carter, MD, to president, Pharmaceutical Research and Development Division; Jerome Birnbaum, PhD, to exec-VP for research, Pharmaceutical Research and Development Division.
You may also be interested in...
Keep Makena Under Accelerated Approval Pending More Studies, AMAG Tells US FDA
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
World-First Nod For Yuhan's Lung Cancer Drug, In Korea
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes Gains US FDA Clearance For Velys Robot For Total Knee Surgery
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: